Replies to post #23215 on RespireRx Pharmaceuticals Inc (RSPI)

[laddadg]

AmpMan,

re: "My suspicion is that we'll PIPE and reverse split, just to appear 'sound' and stay out of pink sheet teritory. I believe we'll quickly (weeks) slide/sink into the below 5 cent/share territory (at today's outstanding shares), and then slowly fade into oblivion".

Getting mixed signals from your post. Since you use the word we, I assume you still own shares in COR. If you truly believe the price will drop 90% (from $.50 to $.05) in the next few weeks, why in the world would you just not get out before the 90% plunge?

My guess is that you (like countless others on this board) are just extremely frustrated by the wait and are letting off a little steam. And that despite your negative comments, you truly believe things will improve over the next few months (whether it be a PIPE, licensing deal, or partnership).

If this is not true, then please cut your losses and move on. Lesson learned.

[myostrain]

Unfortunately, your suspicions are completely warranted when in relation to <5$/Sh biotechs or biotechs without multiple products in market.
Management and development minds of biotech seem to mostly have scientific minds which often do not have the best business insight and reasoning even if there are MBA credentials.
Negative history and stumbling blocks always will breed suspicion.
Probably management has been in discussion with various companies, but management cannot be stubborn with their inner valuation of the pipeline. Hopefully their data is good enough and their ability to sell the data is good enough to get a reasonable deal, back loaded or front loaded. If the data is not as good as we think, then management better modify their perception and take what they can get otherwise the current shareholder value is negligible.
If no discussions are getting close to reasonable, then I would expect a reverse split would have been appropriate in December or early January followed by a pipe.
I am still hoping that what has happened over the year, RD data and hopefully this year-good SA data, there will be very positive share price inducing news.